[
  {
    "ts": null,
    "headline": "S&P Global Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "S&P Global Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=91fe93b0f9c278613a57a3ad05054157ebcf4acecaeeaf5376f4187a451865be",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736872620,
      "headline": "S&P Global Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 132409808,
      "image": "",
      "related": "SPGI",
      "source": "MarketWatch",
      "summary": "S&P Global Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=91fe93b0f9c278613a57a3ad05054157ebcf4acecaeeaf5376f4187a451865be"
    }
  },
  {
    "ts": null,
    "headline": "S&P Places Johnson & Johnson on CreditWatch Negative",
    "summary": "By Connor Hart S&P Global Ratings placed Johnson & Johnson on CreditWatch with negative implications, citing its nearly $15 billion deal to acquire mental-illness drug developer Intra-Cellular...",
    "url": "https://finnhub.io/api/news?id=f567d9705a5c55c6d73750e3f3646dea0da689deba7b7668d2509e76de79e160",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736857394,
      "headline": "S&P Places Johnson & Johnson on CreditWatch Negative",
      "id": 132394772,
      "image": "",
      "related": "SPGI",
      "source": "Finnhub",
      "summary": "By Connor Hart S&P Global Ratings placed Johnson & Johnson on CreditWatch with negative implications, citing its nearly $15 billion deal to acquire mental-illness drug developer Intra-Cellular...",
      "url": "https://finnhub.io/api/news?id=f567d9705a5c55c6d73750e3f3646dea0da689deba7b7668d2509e76de79e160"
    }
  }
]